Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2023

12-02-2023 | Triage | Original Article

Clinical Predictors of Intensive Care Unit Transfer in Admitted Patients with Cirrhosis

Authors: Matthew Dukewich, Chung-Heng Liu, Ethan M Weinberg, Nadim Mahmud, K. Rajender Reddy

Published in: Digestive Diseases and Sciences | Issue 6/2023

Login to get access

Abstract

Background

Patients with cirrhosis are at high risk of mortality after organ failure that requires ICU care. There have been attempts to predict which patients are at highest risk, with some success found in adapting liver disease-specific scoring systems with clinical variables commonly associated with critical illness. However, the clinical factors predictive of which patients with cirrhosis are most at-risk of needing ICU level care are unknown.

Aims

Our study set out to better understand which clinical variables were associated with need for ICU care in patients with cirrhosis.

Methods

Retrospective analysis of admitted patients with cirrhosis at single tertiary care center.

Results

Patients with cirrhosis admitted to our center were categorized into three groups: those without ICU transfer, those admitted to the ICU directly from the emergency department (ED), and those admitted to the ICU from the medicine floor. These groups differed in mortality at 30 days (3.5% vs. 15% vs. 25%, P < 0.001) and at subsequent intervals up to 1 year. These groups differed in indication for ICU transfer, with GI bleed, hemorrhagic shock, hepatic encephalopathy, and hyponatremia occurring more in the ED-to-ICU group, while respiratory failure was more common in the floor-to-ICU group. In multivariable analysis, factors associated with ICU transfer included worsened kidney function, anemia, hyponatremia, leukocytosis, and the decision to obtain a lactate level. Similar analysis with only floor-to-ICU patients found that ICU transfer was associated with hypoalbuminemia, hyponatremia, hypotension, and SIRS score.

Conclusion

Our study found significant differences in mortality among three distinct groups of patients with cirrhosis. A risk factor model for ICU transfer found that variables both specific and nonspecific to liver disease were associated with ICU transfer, with between-group differences supporting the idea of different clinical phenotypes and suggesting factors that should be considered in early triage and assessment of hospitalized patients with cirrhosis.

Graphical Abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference Peery AF, Crockett SD, Barritt AS et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology 2015;149:1731-1741.e3.CrossRefPubMed Peery AF, Crockett SD, Barritt AS et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology 2015;149:1731-1741.e3.CrossRefPubMed
2.
go back to reference Zimmerman JE, Wagner DP, Seneff MG, Becker RB, Sun X, Knaus WA. Intensive care unit admissions with cirrhosis: Risk-stratifying patient groups and predicting individual survival. Hepatology 1996;23:1393–1401.CrossRefPubMed Zimmerman JE, Wagner DP, Seneff MG, Becker RB, Sun X, Knaus WA. Intensive care unit admissions with cirrhosis: Risk-stratifying patient groups and predicting individual survival. Hepatology 1996;23:1393–1401.CrossRefPubMed
3.
go back to reference Levesque E, Saliba F, Ichaï P, Samuel D. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol 2014;60:570–578.CrossRefPubMed Levesque E, Saliba F, Ichaï P, Samuel D. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol 2014;60:570–578.CrossRefPubMed
4.
go back to reference McPhail MJW, Parrott F, Wendon JA, Harrison DA, Rowan KA, Bernal W. Incidence and outcomes for patients with cirrhosis admitted to the united kingdom critical care units*. Crit Care Med 2018;46:705–712.CrossRefPubMedPubMedCentral McPhail MJW, Parrott F, Wendon JA, Harrison DA, Rowan KA, Bernal W. Incidence and outcomes for patients with cirrhosis admitted to the united kingdom critical care units*. Crit Care Med 2018;46:705–712.CrossRefPubMedPubMedCentral
5.
go back to reference da Silva Boteon APC, Chauhan A, Boteon YL et al. Predictive factors for 28-day mortality in acute-on-chronic liver failure patients admitted to the intensive care unit. Digestive and Liver Disease 2019;51:1416–1422.CrossRefPubMed da Silva Boteon APC, Chauhan A, Boteon YL et al. Predictive factors for 28-day mortality in acute-on-chronic liver failure patients admitted to the intensive care unit. Digestive and Liver Disease 2019;51:1416–1422.CrossRefPubMed
6.
go back to reference Campbell J, McPeake J, Shaw M et al. Validation and analysis of prognostic scoring systems for critically ill patients with cirrhosis admitted to ICU. Critical Care 2015;19:364.CrossRefPubMedPubMedCentral Campbell J, McPeake J, Shaw M et al. Validation and analysis of prognostic scoring systems for critically ill patients with cirrhosis admitted to ICU. Critical Care 2015;19:364.CrossRefPubMedPubMedCentral
7.
go back to reference Boone MD, Celi LA, Ho BG et al. Model for end-stage liver disease score predicts mortality in critically ill cirrhotic patients. J Crit Care 2014;29:881.e7-881.e13.CrossRefPubMed Boone MD, Celi LA, Ho BG et al. Model for end-stage liver disease score predicts mortality in critically ill cirrhotic patients. J Crit Care 2014;29:881.e7-881.e13.CrossRefPubMed
8.
go back to reference Levesque E, Hoti E, Azoulay D et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 2012;56:95–102.CrossRefPubMed Levesque E, Hoti E, Azoulay D et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 2012;56:95–102.CrossRefPubMed
9.
go back to reference Ölmez Ş, Gümürdülü Y, Tas A, Karakoq E, Kara B, Kidik A. Prognostic markers in cirrhotic patients requiring intensive care: A comparative prospective study. Annals of Hepatology 2012;11:513–518.CrossRefPubMed Ölmez Ş, Gümürdülü Y, Tas A, Karakoq E, Kara B, Kidik A. Prognostic markers in cirrhotic patients requiring intensive care: A comparative prospective study. Annals of Hepatology 2012;11:513–518.CrossRefPubMed
10.
go back to reference Lindvig KP, Teisner AS, Kjeldsen J et al. Allocation of patients with liver cirrhosis and organ failure to intensive care: Systematic review and a proposal for clinical practice. World J Gastroenterol 2015;21:8964–8973.CrossRefPubMedPubMedCentral Lindvig KP, Teisner AS, Kjeldsen J et al. Allocation of patients with liver cirrhosis and organ failure to intensive care: Systematic review and a proposal for clinical practice. World J Gastroenterol 2015;21:8964–8973.CrossRefPubMedPubMedCentral
11.
go back to reference Balekian AA, Gould MK. Predicting in-hospital mortality among critically ill patients with end-stage liver disease. J Crit Care 2012;27:740.e1-740.e7.CrossRefPubMed Balekian AA, Gould MK. Predicting in-hospital mortality among critically ill patients with end-stage liver disease. J Crit Care 2012;27:740.e1-740.e7.CrossRefPubMed
12.
go back to reference Jalan R, Saliba F, Pavesi M et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014;61:1038–1047.CrossRefPubMed Jalan R, Saliba F, Pavesi M et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014;61:1038–1047.CrossRefPubMed
13.
go back to reference Baudry T, Hernu R, Valleix B et al. Cirrhotic patients admitted to the ICU with septic shock: Factors predicting short and long-term outcome. Shock 2019;52:408–413.CrossRefPubMed Baudry T, Hernu R, Valleix B et al. Cirrhotic patients admitted to the ICU with septic shock: Factors predicting short and long-term outcome. Shock 2019;52:408–413.CrossRefPubMed
14.
go back to reference Spiewak T, Taefi A, Patel S, Li S, Chak E. Racial disparities of Black Americans hospitalized for decompensated liver cirrhosis. BMC Gastroenterol 2020;20:245.CrossRefPubMedPubMedCentral Spiewak T, Taefi A, Patel S, Li S, Chak E. Racial disparities of Black Americans hospitalized for decompensated liver cirrhosis. BMC Gastroenterol 2020;20:245.CrossRefPubMedPubMedCentral
15.
go back to reference Trebicka J, Fernandez J, Papp M et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol 2020;73:842–854.CrossRefPubMed Trebicka J, Fernandez J, Papp M et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol 2020;73:842–854.CrossRefPubMed
16.
go back to reference Anesi GL, Chowdhury M, Small DS et al. Association of a novel index of hospital capacity strain with admission to intensive care units. Annals ATS 2020;17:1440–1447.CrossRef Anesi GL, Chowdhury M, Small DS et al. Association of a novel index of hospital capacity strain with admission to intensive care units. Annals ATS 2020;17:1440–1447.CrossRef
Metadata
Title
Clinical Predictors of Intensive Care Unit Transfer in Admitted Patients with Cirrhosis
Authors
Matthew Dukewich
Chung-Heng Liu
Ethan M Weinberg
Nadim Mahmud
K. Rajender Reddy
Publication date
12-02-2023
Publisher
Springer US
Keywords
Triage
Care
Published in
Digestive Diseases and Sciences / Issue 6/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-07856-x

Other articles of this Issue 6/2023

Digestive Diseases and Sciences 6/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.